IL1B and metabolic disease: Both population studies found that exposure to SO42− affected levels of IL-1β, IL-5, IL-7, IL-12, and IFN-γ, increasing the risk of metabolic syndrome, suggesting that SO42− affects systemic inflammation and metabolic disease [51,52].